Atez/BevAtez/BevatezolizumabdurvalumabtremelimumabHCCDur/Trebevacizumab
…al regimen-specific systemic immune mechanisms in advanced HCC: Atez/Bev amplifies monocyte–NK cytotoxic axes, whereas Dur/Tre enhances …
1articles mentioning treatments
1treatment mentions
1distinct treatments extracted
0%of mentions human-reviewed
Active filtersEntity: Atez/Bev ×
Atez/Bev
This treatment is selected. Its supporting articles are shown below.